FDA-Approved Ebola Treatment Ebanga (fda.gov)

· 17d ago · Report · Spotlight this ·

0xBASE INTEL BRIEF

Ebanga (ansuvimab) is a monoclonal antibody for treating Ebola.
FDA approval based on PALM trial showing significant mortality reduction.
Administered as intravenous infusion.

"The FDA has approved Ebanga (ansuvimab) as a treatment for Ebola. It is a monoclonal antibody that reduces viral load and improves survival. Approval was based on the PALM trial, which showed a significant reduction in mortality when administered early. Ebanga adds to other approved therapies like Inmazeb, expanding the therapeutic arsenal against the disease."

#Ebanga monoclonal antibody #FDA approval #Ebola therapeutic

Read article on fda.gov → | More from fda.gov

FDA-Approved Ebola Treatment Ebanga (fda.gov)

Discussion Matrix